Simona Bramante

Helsinki, 00014, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

WNT2 activation through proximal germline deletion predisposes to small intestinal neuroendocrine tumors and intestinal adenocarcinomas.

WNT2 activation through proximal germline deletion predisposes to small intestinal neuroendocrine tumors and intestinal adenocarcinomas.

Journal: Human molecular genetics

Published: April 23, 2021

Parity associates with chromosomal damage in uterine leiomyomas.

Parity associates with chromosomal damage in uterine leiomyomas.

Journal: Nature communications

Published: January 27, 2020

Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability.

Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability.

Journal: eLife

Published: March 29, 2018

Corrigendum to "Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma".

Corrigendum to "Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma".

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 06, 2016

Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy.

Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy.

Journal: Oncoimmunology

Published: July 11, 2016

Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma.

Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 15, 2016

Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting.

Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting.

Journal: Oncoimmunology

Published: October 22, 2015

Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer.

Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer.

Journal: Oncoimmunology

Published: June 03, 2015

Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues.

Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 28, 2015

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans.

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans.

Journal: International journal of cancer

Published: September 17, 2014

Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma.

Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma.

Journal: International journal of cancer

Published: January 14, 2014

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans.

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans.

Journal: International journal of cancer

Published: June 25, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026